1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Kobe University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy NPC-14, Placebo - Muscular Dystrophy, Duchenne | Phase 2 | Unknown | Kobe University | 21 | 2013-08-01 | 2015-09-03 |
Muscular Dystrophy, Duchenne (1)
arbekacin (1)
Japan (1)
Hirofumi Komaki, MD, PhD (1) · Yasuhiro Takeshima, MD, PhD (1)